News
U.S. kidney transplants grow in number and success
August 24, 2021
Data from 1996 to 2019 show more U.S. kidney transplants recently than ever before, and steady improvements in graft and patient survival.
![1]()
News
SGLT2 inhibitor use rising in patients with DKD
August 23, 2021
Use of SGLT2 inhibitors in patients with type 2 diabetes rose sharply in 2019 and early 2020. GLP-1 RA use also showed recent gains.
![1]()
News
No prehydration prior to contrast-enhanced CT in patients with stage 3 CKD
July 28, 2021
What is the renal safety of omitting prehydration with sodium bicarbonate prior to iodine-based contrast media in patients with stage 3 chronic kidney disease (CKD)?
![1]()
News
Lack of fever in ESRD with S. aureus bacteremia is common
June 30, 2021
What is the incidence of fever in Staphylococcus aureus bacteremic patients with end-stage renal disease (ESRD) presenting to the emergency department?
![1]()
News
Post–acute kidney injury proteinuria predicts subsequent kidney disease progression
June 25, 2021
Does the degree of proteinuria after an episode of acute kidney injury (AKI) predict subsequent loss of kidney function?
![1]()
News
Fact or fiction? Intravascular contrast and acute kidney injury
June 22, 2021
The risks of contrast-associated AKI are overstated, implying the truer danger lies with inadequate imaging.
![1]()
News
For patients with advanced CKD, low risk of nephrogenic systemic fibrosis with group II GBCAs
June 9, 2021
What is the risk of nephrogenic systemic fibrosis (NSF) with use of group II gadolinium-based contrast agents (GBCAs) in patients with chronic kidney disease (CKD) stages IV and V?
![1]()
News
Half of patients in hospital for COVID-19 get acute kidney injury
April 27, 2021
It’s bad news when hospitalized COVID-19 patients develop acute kidney injury, which can prove fatal or can lead to the development or worsening of CKD.
![1]()
News
Thyroid hormone analogues can reverse NASH
April 27, 2021
In patients with nonalcoholic steatohepatitis (NASH) and stages 1-3 fibrosis, does the thyroid hormone receptor beta-agonist, resmetirom reduce hepatic steatosis compared with placebo?
News
‘Major update’ of BP guidance for kidney disease; treat to 120 mm Hg
March 16, 2021
“[Chapter one] of the guidelines is devoted to blood pressure measurement ... if [targeting] 120 [mm Hg systolic], the emphasis is on 120 measured properly.”
